HitGen LTD:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HitGen LTD - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11216
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HitGen LTD (HitGen) is a drug company that concentrates on hit identification and lead generation in the early phases of drug discoveries and development. The company provides OpenDEL, a collection of DNA encoded library compounds based on distinct, diverse and drug structures. It offers biological reagents, edge technology and services for progression of projects and services. HitGen provides services such as lead generation by DNA encoded chemical libraries; hit to lead expansion and lead optimization; custom compound and compound library synthesis and others. The company’s research support capabilities comprise protein expression and purification, chemical library design and synthesis, in-vitro screening and affinity selection, among others. It caters contract research organizations and pharmaceutical industries. HitGen is headquartered in Chengdu, China.

HitGen LTD – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HitGen LTD, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
HitGen Raises USD39.1 Million in Series B Venture Financing 11
Partnerships 12
HitGen Enters into Research Agreement with LG Chem Life Sciences 12
HitGen Enters into Research Collaboration Agreement with Sanofi 13
HitGen Enters into Research Agreement with Boehringer Ingelheim 14
HitGen Enters into Agreement with Takeda Pharma 15
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 16
HitGen Enters into Agreement with Aduro Biotech 17
HitGen Enters into Research Agreement with LEO Pharma 18
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 19
HitGen Expands Agreement with Merck 20
HitGen Enters into Agreement with Janssen Biotech 21
HitGen Enters into Research Agreement with Global Blood Therapeutics 22
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 23
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 24
Licensing Agreements 25
Forma Therapeutics and HitGen Enter into Licensing Agreement 25
HitGen Enters into Licensing Agreement with Simcere Pharma 26
Pfizer Enters into Licensing Agreement with HitGen 27
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 28
HitGen LTD – Key Competitors 29
HitGen LTD – Key Employees 30
HitGen LTD – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Government and Public Interest 32
Aug 03, 2018: HitGen launching initiative to discover new medicines to combat tuberculosis and malaria 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
HitGen LTD, Pharmaceuticals & Healthcare, Key Facts 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Deals By Therapy Area, 2012 to YTD 2018 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HitGen Raises USD39.1 Million in Series B Venture Financing 11
HitGen Enters into Research Agreement with LG Chem Life Sciences 12
HitGen Enters into Research Collaboration Agreement with Sanofi 13
HitGen Enters into Research Agreement with Boehringer Ingelheim 14
HitGen Enters into Agreement with Takeda Pharma 15
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 16
HitGen Enters into Agreement with Aduro Biotech 17
HitGen Enters into Research Agreement with LEO Pharma 18
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 19
HitGen Expands Agreement with Merck 20
HitGen Enters into Agreement with Janssen Biotech 21
HitGen Enters into Research Agreement with Global Blood Therapeutics 22
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 23
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 24
Forma Therapeutics and HitGen Enter into Licensing Agreement 25
HitGen Enters into Licensing Agreement with Simcere Pharma 26
Pfizer Enters into Licensing Agreement with HitGen 27
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 28
HitGen LTD, Key Competitors 29
HitGen LTD, Key Employees 30
HitGen LTD, Subsidiaries 31

List of Figures
HitGen LTD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[HitGen LTD:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Huneed Technologies:企業の戦略・SWOT・財務分析
    Huneed Technologies - Strategy, SWOT and Corporate Finance Report Summary Huneed Technologies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Acer Inc (2353):企業の財務・戦略的SWOT分析
    Acer Inc (2353) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Inabata & Co Ltd (8098):企業の財務・戦略的SWOT分析
    Inabata & Co Ltd (8098) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Hangzhou Tigermed Consulting Co Ltd (300347):企業の財務・戦略的SWOT分析
    Summary Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a contract research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical …
  • Beijing Enterprises Holdings Limited:戦略・SWOT・企業財務分析
    Beijing Enterprises Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Beijing Enterprises Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Haitong Securities Co., Ltd.:戦略・SWOT・企業財務分析
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Total SA (FP):電力:M&Aディール及び事業提携情報
    Summary Total SA (Total) is an integrated global energy company that discovers, produces, refines and markets oil and gas, and also manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distributio …
  • CSC Steel Holdings Berhad:企業の戦略・SWOT・財務情報
    CSC Steel Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary CSC Steel Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Iridex Corp (IRIX):医療機器:M&Aディール及び事業提携情報
    Summary Iridex Corp (Iridex) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company offers products such as lasers, laser delivery devices, glaucoma device …
  • ACWA Power International:企業の戦略的SWOT分析
    ACWA Power International - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • AU Optronics Corp.:企業の戦略・SWOT・財務情報
    AU Optronics Corp. - Strategy, SWOT and Corporate Finance Report Summary AU Optronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Exact Sciences Corp (EXAS):医療機器:M&Aディール及び事業提携情報
    Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the …
  • Brasfield & Gorrie LLC:企業の戦略・SWOT・財務分析
    Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report Summary Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Decathlon S.A.:企業の戦略・SWOT・財務情報
    Decathlon S.A. - Strategy, SWOT and Corporate Finance Report Summary Decathlon S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Phase Holographic Imaging AB:医療機器:M&Aディール及び事業提携情報
    Summary Phase Holographic Imaging AB (PHI) is a medical device company that develops time-lapse cytometry instrumentation and software. The company’s products include HoloMonitor M4 and demo software. Its HoloMonitor time-lapse cytometers provides cellular behavior to be continuously quantified and …
  • Symbiotec Pharmalab Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Symbiotec Pharmalab Ltd (Symbiotec) is a medical laboratory that manufactures active pharmaceutical ingredients. The laboratory develops, produces and markets research-based cortico steroids and steroid-hormone APIs. Its cortico-steroids APIs include clobetasol propionate, betamethasone dipr …
  • Ontario Teachers’ Pension Plan:企業のM&A・事業提携・投資動向
    Ontario Teachers' Pension Plan - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ontario Teachers' Pension Plan Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Amgen Inc (AMGN):医療機器:M&Aディール及び事業提携情報
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • WEC Energy Group Inc:発電所・企業SWOT分析
    WEC Energy Group Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Scientex Bhd (SCIENTX):企業の財務・戦略的SWOT分析
    Summary Scientex Bhd (Scientex) is a manufacturer and supplier of packaging products and component parts for automotive interior. The company operates through stretch and custom film, converting, specialty products and property development divisions. It offers lamination base, general, barrier and a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆